Valuation: LifeMD, Inc.

Market Cap 103M 92.07M 84.94M 77.17M 145M 9.77B 147M 1.02B 403M 5.12B 387M 379M 16.22B P/E 2026 *
-4.18x
P/E 2027 * -23.7x
Enterprise Value 103M 92.07M 84.94M 77.17M 145M 9.77B 147M 1.02B 403M 5.12B 387M 379M 16.22B EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.42x
Free-Float
84.02%
Yield 2026 *
-
Yield 2027 * -
1 day-1.61%
1 week-7.91%
Current month-25.69%
1 month-29.34%
3 months-44.32%
6 months-52.53%
Current year-36.80%
1 week 2.1
Extreme 2.1
2.39
1 month 2.1
Extreme 2.1
3.06
Current year 2.1
Extreme 2.1
5.38
1 year 2.1
Extreme 2.1
6.44
3 years 2.1
Extreme 2.1
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 43 -
Director of Finance/CFO 58 2026-03-15
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 2014-09-03
Chairman 43 2019-06-10
Date Insider Type Main position Quantity % Market Cap. Importance
8/11/26 Free

Director

35,000 0.0724%
8/11/26 Free

Director

35,000 0.0724%
8/11/26 Free

Director

35,000 0.0724%
Change 5-day change 1-year change 3-year change Capi.($)
-1.61%-7.91%-65.41%-67.69% 103M
-1.19%-2.96%+17.07%+44.98% 250B
-1.06%-0.76%+2.05%+11.40% 162B
+2.72%+7.00%-17.19%+67.49% 154B
-1.05%+2.58%-55.53%-9.17% 66.68B
+0.16%+1.04%-15.15%-10.84% 52.08B
+0.14%+4.10%+10.84%+65.58% 52.22B
-0.81%+3.43%+17.04%+29.72% 51.93B
-1.95%-1.12%+15.98%+56.42% 49.02B
-0.90%+3.97%+27.73%+77.70% 44.76B
Average -0.52%+0.17%-6.26%+26.56% 88.24B
Weighted average by Cap. -0.31%+0.54%+1.06%+37.97%

Financials

2026 *2027 *
Net sales 208M 185M 171M 155M 291M 19.66B 296M 2.06B 811M 10.3B 779M 763M 32.64B 245M 219M 202M 183M 344M 23.22B 349M 2.43B 958M 12.16B 920M 900M 38.54B
Net income -24.81M -22.14M -20.43M -18.56M -34.82M -2.35B -35.35M -246M -96.94M -1.23B -93.11M -91.12M -3.9B -4.54M -4.06M -3.74M -3.4M -6.38M -430M -6.48M -45.08M -17.76M -226M -17.06M -16.69M -715M
Net Debt - -
Projected Income Statement - Annual - LifeMD, Inc.
Logo LifeMD, Inc.
LifeMD, Inc. is a patient-centric, direct-to-patient healthcare company. The Company is engaged in providing patients access to virtual medical care and pharmacy services. Its telehealth platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring basis and sells over the counter (OTC) products. Its products are available on a subscription or membership basis, where a patient can subscribe to receive regular shipments of prescribed medications or products. The Company's men's brand, RexMD, offers access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation and hair loss. Its vertically integrated care model combines technology, affiliated clinical services, pharmacy infrastructure, and artificial intelligence (AI)-enabled operational systems to deliver longitudinal care.
Employees
350
Date Price Change Volume
26-10-23 US$2.145 -1.15% 124,599
26-10-22 US$2.170 +1.40% 674,289
26-10-21 US$2.140 -4.68% 628,314
26-10-20 US$2.245 -0.22% 699,726
26-10-19 US$2.250 -3.85% 784,413
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - LifeMD, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.170USD
Average target price
8.125USD
Spread / Average Target
+274.42%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LifeMD, Inc.
  1. Stock Market
  2. Stocks
  3. LFMD Stock